Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2017 | 1 |
2018 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway.
Pharmacol Ther. 2018 Jul;187:45-60. doi: 10.1016/j.pharmthera.2018.02.007. Epub 2018 Feb 16.
Pharmacol Ther. 2018.
PMID: 29454854
Review.
De-RSKing ERK - regulation of ERK1/2-RSK dissociation by phosphorylation within a disordered motif.
Kidger AM, Cook SJ.
Kidger AM, et al.
FEBS J. 2018 Jan;285(1):42-45. doi: 10.1111/febs.14344.
FEBS J. 2018.
PMID: 29314599
Free article.
Item in Clipboard
Control of cell death and mitochondrial fission by ERK1/2 MAP kinase signalling.
Cook SJ, Stuart K, Gilley R, Sale MJ.
Cook SJ, et al.
FEBS J. 2017 Dec;284(24):4177-4195. doi: 10.1111/febs.14122. Epub 2017 Jun 18.
FEBS J. 2017.
PMID: 28548464
Free PMC article.
Review.
Item in Clipboard
The BH3 mimetic ABT-263 synergizes with the MEK1/2 inhibitor selumetinib/AZD6244 to promote BIM-dependent tumour cell death and inhibit acquired resistance.
Sale MJ, Cook SJ.
Sale MJ, et al.
Biochem J. 2013 Mar 1;450(2):285-94. doi: 10.1042/BJ20121212.
Biochem J. 2013.
PMID: 23234544
Item in Clipboard
Cite
Cite